Riders · Sam Houston State University College of Osteopathic Medicine · Article III: Agencies of Education

Contingency for Formula Funding

Rider 4 in the 2024-25 Act, page III-237

This rider is not in the Introduced (Senate) or any later version.

Through the session

  1. 2024-25 Act In current law rider 4
  2. Introduced (Senate) Dropped
  3. Introduced (House) Not in this version
  4. Senate substitute Not in this version
  5. House substitute Not in this version
  6. House passed Not in this version
  7. Conference Not in this version
  8. 2026-27 Act Not in this version

Pick any two steps to compare their wording.

Every version: numbers, statuses and source pages
VersionRider Against the version beforeAgainst the current budget Source
2024-25 ActGeneral Appropriations Act, 2024-25 Biennium 4 First version — Page III-237
Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) Not in this version
Introduced (House)House Bill 1 as introduced (LBB recommended, House) Not in this version
Senate substituteCommittee Substitute for Senate Bill 1 Not in this version
House substituteHouse Committee Substitute for Senate Bill 1 Not in this version
House passedSenate Bill 1 as passed the second house Not in this version
ConferenceConference Committee Report for Senate Bill 1 Not in this version
2026-27 ActGeneral Appropriations Act, 2026-27 Biennium Not in this version
Full text of each wording

2024-25 Act

Source, page III-237

Contingency for Formula Funding. Included in the amounts above to Sam Houston State University College of Osteopathic Medicine are $32,321,584 in General Revenue and $2,112,024 in GR-Dedicated Account No. 770 for the 2024-25 biennium to support instruction and operation, research enhancement, and educational space support contingent on the enactment of legislation by the Eighty-eighth Legislature, Regular Session relating to the modification of Section 96.66(h) of the Texas Education Code to allow for the Sam Houston State University College of Osteopathic Medicine to attain eligibility for state appropriated formula funding.